Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

418 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
LAG-3 regulates plasmacytoid dendritic cell homeostasis.
Workman CJ, Wang Y, El Kasmi KC, Pardoll DM, Murray PJ, Drake CG, Vignali DA. Workman CJ, et al. Among authors: drake cg. J Immunol. 2009 Feb 15;182(4):1885-91. doi: 10.4049/jimmunol.0800185. J Immunol. 2009. PMID: 19201841 Free PMC article.
Cutting edge: accelerated autoimmune diabetes in the absence of LAG-3.
Bettini M, Szymczak-Workman AL, Forbes K, Castellaw AH, Selby M, Pan X, Drake CG, Korman AJ, Vignali DA. Bettini M, et al. Among authors: drake cg. J Immunol. 2011 Oct 1;187(7):3493-8. doi: 10.4049/jimmunol.1100714. Epub 2011 Aug 26. J Immunol. 2011. PMID: 21873518 Free PMC article.
Immune inhibitory molecules LAG-3 and PD-1 synergistically regulate T-cell function to promote tumoral immune escape.
Woo SR, Turnis ME, Goldberg MV, Bankoti J, Selby M, Nirschl CJ, Bettini ML, Gravano DM, Vogel P, Liu CL, Tangsombatvisit S, Grosso JF, Netto G, Smeltzer MP, Chaux A, Utz PJ, Workman CJ, Pardoll DM, Korman AJ, Drake CG, Vignali DA. Woo SR, et al. Among authors: drake cg. Cancer Res. 2012 Feb 15;72(4):917-27. doi: 10.1158/0008-5472.CAN-11-1620. Epub 2011 Dec 20. Cancer Res. 2012. PMID: 22186141 Free PMC article.
Role of LAG-3 in regulatory T cells.
Huang CT, Workman CJ, Flies D, Pan X, Marson AL, Zhou G, Hipkiss EL, Ravi S, Kowalski J, Levitsky HI, Powell JD, Pardoll DM, Drake CG, Vignali DA. Huang CT, et al. Among authors: drake cg. Immunity. 2004 Oct;21(4):503-13. doi: 10.1016/j.immuni.2004.08.010. Immunity. 2004. PMID: 15485628 Free article.
The composition and signaling of the IL-35 receptor are unconventional.
Collison LW, Delgoffe GM, Guy CS, Vignali KM, Chaturvedi V, Fairweather D, Satoskar AR, Garcia KC, Hunter CA, Drake CG, Murray PJ, Vignali DA. Collison LW, et al. Among authors: drake cg. Nat Immunol. 2012 Feb 5;13(3):290-9. doi: 10.1038/ni.2227. Nat Immunol. 2012. PMID: 22306691 Free PMC article.
LAG3 (CD223) as a cancer immunotherapy target.
Andrews LP, Marciscano AE, Drake CG, Vignali DA. Andrews LP, et al. Among authors: drake cg. Immunol Rev. 2017 Mar;276(1):80-96. doi: 10.1111/imr.12519. Immunol Rev. 2017. PMID: 28258692 Free PMC article. Review.
418 results